| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-05 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |